AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

PROTEOMICS INTERNATIONAL LAB

0.445

+0.000

Volume:- -

Turnover:- -

Market Cap:58.30M

PE:-8.64

High:0.445

Open:0.445

Low:0.445

Close:0.445

Loading ...

Overview Company News Filings

Proteomics International Laboratories Ltd - Seeks Trading Halt Pending Announcement on Capital Raise

THOMSON REUTERS

Proteomics International Laboratories Forms Advisory Board for Cancer Diagnostic Test; Shares Down 8%

MT Newswires Live

Proteomics Says Unit Obtains New Australian Patent for Oxidative Stress Diagnostic Test; Shares Up 4%

MT Newswires Live

BRIEF-Proteomics International Laboratories Says Patent Granted For Oxidx Oxidative Stress Test

Proteomics International Laboratories Ltd - Australian Patent Granted for Oxidx Oxidative Stress Test

THOMSON REUTERS

Proteomics Opens Certified Clinical Laboratory in California; Shares Fall 8%

MT Newswires Live

Proteomics' Direct-to-Consumer Strategy to Commercialize Diagnostic Tests May Face Delays, Euroz Hartleys Says

MT Newswires Live

BUZZ-Australia's Proteomics International jumps on new stress test for marathon runners

Proteomics International Unit's Muscle Damage Test Shows Potential in Study of Athletes

MT Newswires Live

Australian Shares Inch Down Amid Wall Street Losses; Astral Resources Submits Proposal to Acquire Maximus Resources

MT Newswires Live

ASX Market Close: More red for Oz investors as 2024 drags into station | Dec 30, 2024

The Market Herald

Proteomics International Validates Endometriosis Biomarker for Diagnostic Test; Shares Climb 22%

MT Newswires Live

BUZZ-Australia's Proteomics International jumps on endometriosis panel results

ASX Penny Stock Highlights: Energy Transition Minerals And Two Other Picks

Simply Wall St.

Proteomics International Laboratories (ASX:PIQ) shareholders have earned a 18% CAGR over the last five years

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/PIQ.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PIQ.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PIQ.AU\",,,,,undefined,":{"symbol":"PIQ.AU","market":"AU","secType":"STK","nameCN":"PROTEOMICS INTERNATIONAL LAB","latestPrice":0.445,"timestamp":1744870320000,"preClose":0.445,"halted":3,"volume":0,"delay":0,"nameEN":"PROTEOMICS INTERNATIONAL LAB","floatShares":90111464,"shares":131002718,"eps":-0.051492,"marketStatus":"Halted","change":0,"latestTime":"04-17 16:12:00 AEST","open":0.445,"high":0.445,"low":0.445,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.051492,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1745280000000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.445,"openAndCloseTimeList":[[1744848000000,1744869600000]],"volumeRatio":0,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PIQ.AU\",,,,,undefined,":{"symbol":"PIQ.AU","floatShares":90111464,"roa":"-66.25%","roe":"-136.44%","lyrEps":-0.050665,"shares":131002718,"dividePrice":0,"high":0.445,"amplitude":0,"preClose":0.445,"low":0.445,"week52Low":0.365,"pbRate":"10.68","psRate":"16.68","week52High":1.15,"institutionHeld":0,"latestPrice":0.445,"eps":-0.051492,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.051492,"open":0.445,"prevYearClose":0.8,"prevWeekClose":0.445,"prevMonthClose":0.5,"prevQuarterClose":0.5,"fiveDayClose":0.46,"twentyDayClose":0.51,"sixtyDayClose":0.69},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PIQ.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2527405917","title":"Proteomics International Laboratories Ltd - Seeks Trading Halt Pending Announcement on Capital Raise","url":"https://stock-news.laohu8.com/highlight/detail?id=2527405917","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527405917?lang=en_us&edition=fundamental","pubTime":"2025-04-16 08:57","pubTimestamp":1744765044,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250416:nFWN3QT2HQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7048","PIQ.AU","BK7508"],"gpt_icon":0},{"id":"2525037619","title":"Proteomics International Laboratories Forms Advisory Board for Cancer Diagnostic Test; Shares Down 8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2525037619","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525037619?lang=en_us&edition=fundamental","pubTime":"2025-04-07 10:46","pubTimestamp":1743994010,"startTime":"0","endTime":"0","summary":"Proteomics International Laboratories  formed its clinical advisory board for PromarkerEso, a diagnostic blood test for esophageal cancer, according to a Monday filing with the Australian bourse.The advisory board will provide guidance and clinical insights for the global commercialization of PromarkerEso, the filing said.The company is set to launch PromarkerEso in Australia, with other jurisdictions expected to follow, per the filing.Shares fell 8% in recent trade on Monday.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7048","XAO.AU","XJO.AU","BK7508","XKO.AU","PIQ.AU"],"gpt_icon":0},{"id":"2522598046","title":"Proteomics Says Unit Obtains New Australian Patent for Oxidative Stress Diagnostic Test; Shares Up 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2522598046","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522598046?lang=en_us&edition=fundamental","pubTime":"2025-03-28 11:40","pubTimestamp":1743133202,"startTime":"0","endTime":"0","summary":"Proteomics International Laboratories'  OxiDx subsidiary obtained a new Australian patent for the OxiDx oxidative stress diagnostic test, according to a Friday filing with the Australian bourse.OxiDx was designed to detect oxidative stress through a finger-prick blood sample.The second-generation patent, valid until March 2039, follows similar patents in Europe and Japan. The company's original OxiDx patents cover Australia and the US and are valid until 2026 and 2028, respectively, per the filing.The second-generation patent is pending in the US, Singapore, India, and China, the filing added.The diagnostics company's shares were up 4% in recent Friday trade.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PIQ.AU","XAO.AU","XKO.AU","BK7048","BK7508","XJO.AU"],"gpt_icon":0},{"id":"2522360563","title":"BRIEF-Proteomics International Laboratories Says Patent Granted For Oxidx Oxidative Stress Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2522360563","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522360563?lang=en_us&edition=fundamental","pubTime":"2025-03-28 09:17","pubTimestamp":1743124679,"startTime":"0","endTime":"0","summary":"BRIEF-Proteomics International Laboratories Says Patent Granted For Oxidx Oxidative Stress TestMarch 28 (Reuters) - Proteomics International Laboratories PIQ.AX:AUSTRALIAN PATENT GRANTED FOR OXIDX OXIDATIVE STRESS TESTFurther company coverage: PIQ.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250328:nFWN3QA1DJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PIQ.AU","BK7508","BK7048"],"gpt_icon":0},{"id":"2522153777","title":"Proteomics International Laboratories Ltd - Australian Patent Granted for Oxidx Oxidative Stress Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2522153777","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522153777?lang=en_us&edition=fundamental","pubTime":"2025-03-28 05:27","pubTimestamp":1743110855,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250327:nFWN3QA1DJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","PIQ.AU","BK7048"],"gpt_icon":0},{"id":"2514393082","title":"Proteomics Opens Certified Clinical Laboratory in California; Shares Fall 8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514393082","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514393082?lang=en_us&edition=fundamental","pubTime":"2025-02-28 12:18","pubTimestamp":1740716328,"startTime":"0","endTime":"0","summary":"Proteomics International Laboratories  has opened a clinical laboratory improvement amendments  certified reference laboratory in Irvine, California, according to a Friday filing with the Australian bourse.The company has secured both a California State License and the CLIA certification, allowing it to operate as a certified clinical laboratory within the US, the filing said.The laboratory will initially offer the PromarkerD test, which predicts diabetes-related chronic kidney disease , and plans to expand with tests for esophageal cancer and endometriosis, the filing added.The launch of PromarkerD, shown to predict DKD up to four years in advance, is expected in the second quarter, the company said.The laboratory is designed for scalability, allowing Proteomics International to introduce additional diagnostic tests efficiently in the US market, the company added.Shares of the company fell 8% in recent Friday trade.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CLIA","BK7048","BK7508","PIQ.AU"],"gpt_icon":0},{"id":"2505337980","title":"Proteomics' Direct-to-Consumer Strategy to Commercialize Diagnostic Tests May Face Delays, Euroz Hartleys Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2505337980","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505337980?lang=en_us&edition=fundamental","pubTime":"2025-01-23 10:39","pubTimestamp":1737599961,"startTime":"0","endTime":"0","summary":"Proteomics International Laboratories  may face delays in executing its direct-to-consumer strategy in commercializing its diagnostic tests for diabetes, endometriosis, and esophageal cancer, according to a Tuesday note from Euroz Hartleys.The company has reaffirmed its plan for the US launch in the first half of 2025 of its lead diagnostic test PromarkerD for detecting diabetic kidney disease, adding that it remains on track for an Australian launch of the test in the first quarter of 2025.Euroz Hartleys believes that the commercialization could take longer than expected, citing potential execution risks with the direct-to-consumer pathway.Euroz Hartleys notes that the partners in place in other territories have only covered the pre-launch of PIQ's tests in smaller markets.The firm maintained a hold rating and price target of AU$0.72 on Proteomics.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7508","PIQ.AU","BK7048"],"gpt_icon":0},{"id":"2495854216","title":"BUZZ-Australia's Proteomics International jumps on new stress test for marathon runners","url":"https://stock-news.laohu8.com/highlight/detail?id=2495854216","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495854216?lang=en_us&edition=fundamental","pubTime":"2024-12-31 08:43","pubTimestamp":1735605797,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Proteomics International jumps on new stress test for marathon runners** Proteomics International Laboratories PIQ.AX jumps as much as 9.5% to A$0.810, highest since Oct. 11** Medical technology firm says its OxiDx test - a finger-prick blood test to measure oxidative stress - accurately identifies muscle damage in marathon runners** PIQ sets sights on H1 CY25 for Australian commercial launch of OxiDx test** More than 540,000 shares traded, 5x the 30-day avg** Stock trims YTD losses to 12.3%  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241231:nL4N3NW00H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7048","BK7508","PIQ.AU"],"gpt_icon":0},{"id":"2495501179","title":"Proteomics International Unit's Muscle Damage Test Shows Potential in Study of Athletes","url":"https://stock-news.laohu8.com/highlight/detail?id=2495501179","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495501179?lang=en_us&edition=fundamental","pubTime":"2024-12-31 06:28","pubTimestamp":1735597683,"startTime":"0","endTime":"0","summary":"Proteomics International Laboratories  subsidiary OxiDx's diagnostic testing technology showed a potential to identify muscle damage and recovery among athletes via a finger prick blood test, according to a Tuesday filing with the Australian bourse.Based on a study of 20 marathon runners, the OxiDx diagnostic test was able to measure and assess exercise-induced muscle damage, the filing said.Results were published in the Physiological Reports journal.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7508","BK7048","PIQ.AU"],"gpt_icon":0},{"id":"2495981605","title":"Australian Shares Inch Down Amid Wall Street Losses; Astral Resources Submits Proposal to Acquire Maximus Resources","url":"https://stock-news.laohu8.com/highlight/detail?id=2495981605","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495981605?lang=en_us&edition=fundamental","pubTime":"2024-12-30 14:05","pubTimestamp":1735538758,"startTime":"0","endTime":"0","summary":"Australian shares inch down Monday's close, tracking Wall Street markets as investors remained uncertain about the new year.The S&P/ASX 200 Index fell 0.3% or 26.8 points to close at 8,231.The day saw thin trading with investors becoming risk-averse ahead of uncertainties surrounding the new year, Bloomberg reported.In company news, Astral Resources  submitted a non-binding indicative proposal to acquire Maximus Resources  for AU$0.07 per share in an all-scrip, off-market takeover. Shares of Astral Resources fell 7%, while shares of Maximus Resources soared 31% at market close.Woolworths Group  said customers of its Everyday car insurance will receive refunds after the retailer discovered they had been overcharged by its underwriter for several years, The Australian reported.Lastly, Proteomics International Laboratories  validated the use of a plasma protein biomarker to detect endometriosis via the PromarkerEndo diagnosis test. The company's shares surged past 22% at market close.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7040","BK7508","BK7501","MMS","PIQ.AU","XJO.AU","BK7095","XAO.AU","BK4106","BK4226","MXR.AU","BK7104","WOW.AU","XKO.AU","AAR.AU","BK7511","BK7048"],"gpt_icon":0},{"id":"2495959380","title":"ASX Market Close: More red for Oz investors as 2024 drags into station | Dec 30, 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2495959380","media":"The Market Herald","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495959380?lang=en_us&edition=fundamental","pubTime":"2024-12-30 13:44","pubTimestamp":1735537440,"startTime":"0","endTime":"0","summary":"The ASX closed down 0.04% on the second last trading day of 2024, losing three points to drop down to 8,221 as slow trade and profit-taking raked markets.The last full day of trading  was awash with red – only two of the 11 sectors on the ASX managed to stay positively green in any real way.Those two up sectors were Energy, up 1.12% at close, and Healthcare, up 0.09%, the latter of which was buoyed by Proteomics International  and its 22.3% rocket up.Real Estate had the biggest dip through today, shedding 1.79%. It was followed by Financials, down 0.51% after the big four banks dropped slightly, and Utilities, dragged down 0.42% by APA Group  and Origin .Boss Energy  and Karoon Energy  both gained today too, up 0.84% and 3.8% respectively after crude oil prices bumped up to start the week.Also among the big winners was coal maker Bowen Coking Coal , up 29%.Join the discussion:Seewhat’s trending right nowon Australia’s largest stock forum and be part of the conversations that move the m","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://themarketonline.com.au/asx-market-close-more-red-for-oz-investors-as-2024-drags-into-station-dec-30-2024-2024-12-30/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"markerherald_stock","symbols":["GPT.AU","BK7154","GMG.AU","APA.AU","BCB.AU","KAR.AU","ORG.AU","BK7142","MXR.AU","BK7508","BK7090","TCL.AU","AAR.AU","BK7099","BK7006","BK7095","BK7087","BK7155","DXS.AU","PIQ.AU","BK7148","BK7130","BK7507","BK7510","BK7129","BK7104","BK7048","BK7083","BOE.AU","BK7122"],"gpt_icon":0},{"id":"2495561795","title":"Proteomics International Validates Endometriosis Biomarker for Diagnostic Test; Shares Climb 22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2495561795","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495561795?lang=en_us&edition=fundamental","pubTime":"2024-12-30 12:14","pubTimestamp":1735532050,"startTime":"0","endTime":"0","summary":"Proteomics International Laboratories  validated the use of a plasma protein biomarker to detect endometriosis via the PromarkerEndo diagnosis test, according to a Monday filing with the Australian bourse.A recent study showed that the test was able to separate healthy individuals with endometriosis patients using the biomarker, the filing said.Results were published in the journal Human Reproduction, as per the filing.The company's shares surged past 22% in recent Monday trade.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7508","PIQ.AU","BK7048"],"gpt_icon":0},{"id":"2495517135","title":"BUZZ-Australia's Proteomics International jumps on endometriosis panel results","url":"https://stock-news.laohu8.com/highlight/detail?id=2495517135","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495517135?lang=en_us&edition=fundamental","pubTime":"2024-12-30 09:09","pubTimestamp":1735520973,"startTime":"0","endTime":"0","summary":"** Shares of Proteomics International Laboratories    surge as much as 24% to A$0.750, their biggest one-day pct gain since Oct. 8   ** Medical technology firm reports that its PromarkerEndo plasma protein biomarker panel accurately identifies all stages of endometriosis   ** Endometriosis is a condition causing uterine-like tissue growth outside the uterus, affecting roughly 10% of reproductive age women and girls according to the WHO   ** The condition takes an average of seven years to diagnose   ** PIQ sets sights on Q2 CY25 for Australian launch of its product   ** Stock hits its highest level since Oct. 29   ** Including session's moves, stock trims YTD losses to 19% as of 0050 GMT ","market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","XAO.AU","XKO.AU","XJO.AU","PIQ.AU","BK7048"],"gpt_icon":0},{"id":"2491730366","title":"ASX Penny Stock Highlights: Energy Transition Minerals And Two Other Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2491730366","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491730366?lang=en_us&edition=fundamental","pubTime":"2024-12-13 07:08","pubTimestamp":1734044932,"startTime":"0","endTime":"0","summary":"As the ASX 200 faces a potential decline, reflecting broader global market jitters, investors are keenly observing opportunities that may arise amidst these fluctuations. Penny stocks, while often considered niche investments, can still present intriguing growth prospects when backed by strong financial fundamentals. In this context, we will highlight three penny stocks that demonstrate financial resilience and potential for long-term success in the Australian market.Overview: Energy Transition Minerals Ltd is engaged in mineral exploration and evaluation activities in Australia, with a market cap of A$40.85 million.Overview: Proteomics International Laboratories Ltd is a medical technology company specializing in proteomics across Australia, New Zealand, the United States, Europe, India, and South East Asia with a market cap of A$89.08 million.Operations: The company generates revenue of A$3.28 million from its operational activities in the medical techn","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/qUsXHnhTq9BjFq.vX6I3sw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/b7362375b2727bfdfe4eb144bcc3fe6a","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/qUsXHnhTq9BjFq.vX6I3sw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/b7362375b2727bfdfe4eb144bcc3fe6a"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/asx-penny-stock-highlights-energy-230852540.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["MTX","SKS.AU","PIQ.AU","BK7023","ANG.AU","BK7077","XJO.AU","EVO.AU","BK7506","BK7132","VLS.AU","BK7133","BK7088","BK7095","XKO.AU","SRV.AU","BK7096","WC8.AU","SHA.AU","BK7508","BK7048","LBL.AU","MXI.AU","XAO.AU","BK4109","BK7062","BK7164","BK7070","ETM.AU","NGI.AU","HLO.AU","BK7055"],"gpt_icon":0},{"id":"2477040170","title":"Proteomics International Laboratories (ASX:PIQ) shareholders have earned a 18% CAGR over the last five years","url":"https://stock-news.laohu8.com/highlight/detail?id=2477040170","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477040170?lang=en_us&edition=fundamental","pubTime":"2024-10-21 08:44","pubTimestamp":1729471459,"startTime":"0","endTime":"0","summary":"It hasn't been the best quarter for Proteomics International Laboratories Ltd  shareholders, since the share price has fallen 14% in that time. But that scarcely detracts from the really solid long term returns generated by the company over five years. It's fair to say most would be happy with 126% the gain in that time. We think it's more important to dwell on the long term returns than the short term returns. The more important question is whether the stock is too cheap or too expensive today.So let's investigate and see if the longer term performance of the company has been in line with the underlying business' progress.See our latest analysis for Proteomics International Laboratories","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/qUsXHnhTq9BjFq.vX6I3sw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/b7362375b2727bfdfe4eb144bcc3fe6a","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/qUsXHnhTq9BjFq.vX6I3sw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/b7362375b2727bfdfe4eb144bcc3fe6a"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/proteomics-international-laboratories-asx-piq-004419783.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["BK7048","BK7508","PIQ.AU"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":15,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PIQ.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PIQ.AU\",market:\"AU\",,,undefined,":[]}}